JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias

Andrade J, Connolly S, Dorian P, Green M, Humphries K, Klein G . Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II). Heart Rhythm. 2010; 7(9):1171-7. DOI: 10.1016/j.hrthm.2010.04.026. View

Lip G, Collet J, De Caterina R, Fauchier L, Lane D, Larsen T . Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC.... Europace. 2017; 19(11):1757-1758. DOI: 10.1093/europace/eux240. View

Olshansky B, Okumura K, Hess P, Henthorn R, Waldo A . Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm. J Am Coll Cardiol. 1988; 11(2):359-64. DOI: 10.1016/0735-1097(88)90102-7. View

Rensma P, Allessie M, Lammers W, Bonke F, Schalij M . Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res. 1988; 62(2):395-410. DOI: 10.1161/01.res.62.2.395. View

Washam J, Stevens S, Lokhnygina Y, Halperin J, Breithardt G, Singer D . Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism.... Lancet. 2015; 385(9985):2363-70. DOI: 10.1016/S0140-6736(14)61836-5. View

Kushimoto S, Fukuoka T, Kimura A, Toyoda K, Brainsky A, Harman A . Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm.... Int J Hematol. 2017; 106(6):777-786. DOI: 10.1007/s12185-017-2311-4. View

Jais P, Shah D, Haissaguerre M, Hocini M, Peng J, Takahashi A . Mapping and ablation of left atrial flutters. Circulation. 2000; 101(25):2928-34. DOI: 10.1161/01.cir.101.25.2928. View

Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T . Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. 1997; 28(12):2370-5. DOI: 10.1161/01.str.28.12.2370. View

Ruff C, Giugliano R, Braunwald E, Morrow D, Murphy S, Kuder J . Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Lancet. 2015; 385(9984):2288-95. DOI: 10.1016/S0140-6736(14)61943-7. View

10.

Morrison T, Rea R, Hodge D, Crusan D, Koestler C, Asirvatham S . Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead. J Cardiovasc Electrophysiol. 2010; 21(6):671-7. DOI: 10.1111/j.1540-8167.2009.01683.x. View

11.

Batra A, Chun D, Johnson T, Maldonado E, Kashyap B, Maiers J . A prospective analysis of the incidence and risk factors associated with junctional ectopic tachycardia following surgery for congenital heart disease. Pediatr Cardiol. 2006; 27(1):51-55. DOI: 10.1007/s00246-005-0992-6. View

12.

. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med. 1998; 128(8):639-47. DOI: 10.7326/0003-4819-128-8-199804150-00005. View

13.

El-Sherif N, Boutjdir M . Role of pharmacotherapy in cardiac ion channelopathies. Pharmacol Ther. 2015; 155:132-42. DOI: 10.1016/j.pharmthera.2015.09.002. View

14.

Cook J, Steinberg J . An incessant form of junctional ectopic tachycardia in an adult responsive to a class 1C agent. Am Heart J. 1991; 122(5):1487-9. DOI: 10.1016/0002-8703(91)90602-e. View

15.

Murakawa Y, Yamashita T, Kanese Y, Omata M . Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation?. J Am Coll Cardiol. 1997; 29(3):688-92. DOI: 10.1016/s0735-1097(96)00559-1. View

16.

Brignole M, Deharo J, De Roy L, Menozzi C, Blommaert D, Dabiri L . Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol. 2011; 58(2):167-73. DOI: 10.1016/j.jacc.2010.12.045. View

17.

Tomita H, Okumura K, Inoue H, Atarashi H, Yamashita T, Origasa H . Validation of Risk Scoring System Excluding Female Sex From CHA2DS2-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry. Circ J. 2015; 79(8):1719-26. DOI: 10.1253/circj.CJ-15-0095. View

18.

Dinov B, Fiedler L, Schonbauer R, Bollmann A, Rolf S, Piorkowski C . Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation. 2013; 129(7):728-36. DOI: 10.1161/CIRCULATIONAHA.113.003063. View

19.

Zelniker T, Ruff C, Antman E, Giugliano R . The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trials. Eur Heart J Acute Cardiovasc Care. 2018; 8(6):554-561. DOI: 10.1177/2048872618796990. View

20.

Mazur A, Meisel S, Shotan A, Strasberg B . The mechanism of sudden death in the Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol. 2006; 16(12):1393. DOI: 10.1111/j.1540-8167.2005.00256.x. View